Tenet Healthcare Corporation $THC Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al reduced its position in Tenet Healthcare Corporation (NYSE:THC) by 20.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,321 shares of the company’s stock after selling 6,100 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Tenet Healthcare were worth $5,960,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Talon Private Wealth LLC lifted its stake in shares of Tenet Healthcare by 35.4% in the second quarter. Talon Private Wealth LLC now owns 23,097 shares of the company’s stock valued at $4,321,000 after buying an additional 6,044 shares in the last quarter. CX Institutional bought a new stake in shares of Tenet Healthcare during the third quarter worth about $6,415,000. Counterpoint Mutual Funds LLC acquired a new stake in shares of Tenet Healthcare in the 3rd quarter worth about $9,593,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Tenet Healthcare in the 2nd quarter worth about $10,144,000. Finally, Wedge Capital Management L L P NC lifted its position in Tenet Healthcare by 37.6% in the 2nd quarter. Wedge Capital Management L L P NC now owns 221,453 shares of the company’s stock valued at $41,429,000 after acquiring an additional 60,478 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported third-quarter earnings of $6.64 per share, well above the $4.68 consensus estimate, while revenue rose 6.5% year over year to $6.28 billion versus expectations of $5.49 billion. Strong hospital performance and cost discipline drove the earnings beat. Tenet Healthcare surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Management raised its 2026 financial outlook and forecast adjusted EBITDA of $5.05 billion to $5.20 billion. Conifer transition-related items are expected to contribute to results, while improving hospital margins and higher-acuity services are strengthening the business outlook. Tenet forecasts 2026 adjusted EBITDA
• Positive Sentiment: Deutsche Bank raised its price target to $320 from $260 and maintained a Buy rating, signaling increased confidence in Tenet’s earnings momentum and valuation potential. Deutsche Bank raises Tenet price target
• Neutral Sentiment: Guggenheim modestly reduced its price target to $306 from $307 but retained a Buy rating, leaving its fundamental view constructive. Guggenheim Tenet Healthcare rating
• Negative Sentiment: Investors continue to face risks from payer pressure, uninsured patients and surgery-related headwinds. Commentary also noted that the headline earnings beat included transition-related benefits, which could make the results less representative of recurring performance. Tenet high-acuity strategy and third-quarter performance

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on THC. Truist Financial raised their target price on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a report on Tuesday, July 28th. Morgan Stanley increased their price target on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research report on Monday, July 27th. Zacks Research downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 29th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 17th. Finally, Leerink Partners reiterated an “outperform” rating and issued a $309.00 target price on shares of Tenet Healthcare in a report on Friday, September 18th. Eighteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and an average price target of $280.16.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $273.25 on Monday. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $283.05. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. The firm has a 50 day moving average price of $264.85 and a 200-day moving average price of $220.34. The company has a market capitalization of $21.75 billion, a P/E ratio of 7.92, a P/E/G ratio of 1.03 and a beta of 1.20.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating analysts’ consensus estimates of $4.68 by $1.96. The firm had revenue of $6.28 billion for the quarter, compared to analysts’ expectations of $5.49 billion. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The business’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.70 EPS. As a group, equities analysts predict that Tenet Healthcare Corporation will post 21.98 EPS for the current year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director J. Robert Kerrey sold 12,010 shares of the business’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the sale, the director owned 4,794 shares of the company’s stock, valued at $1,264,273.68. The trade was a 71.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Lisa Y. Foo sold 24,000 shares of the firm’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares of the company’s stock, valued at $2,144,674.96. The trade was a 74.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 106,484 shares of company stock valued at $28,898,063. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.